rs145493619
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 1P and 5B. PP3BP4_StrongBP6
The NM_153026.3(PRICKLE1):c.113C>T(p.Pro38Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000255 in 1,613,742 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P38P) has been classified as Likely benign.
Frequency
Consequence
NM_153026.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PRICKLE1 | NM_153026.3 | c.113C>T | p.Pro38Leu | missense_variant | 2/8 | ENST00000345127.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PRICKLE1 | ENST00000345127.9 | c.113C>T | p.Pro38Leu | missense_variant | 2/8 | 1 | NM_153026.3 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000138 AC: 21AN: 152046Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000307 AC: 77AN: 250986Hom.: 0 AF XY: 0.000354 AC XY: 48AN XY: 135674
GnomAD4 exome AF: 0.000267 AC: 390AN: 1461578Hom.: 3 Cov.: 31 AF XY: 0.000268 AC XY: 195AN XY: 727094
GnomAD4 genome ? AF: 0.000138 AC: 21AN: 152164Hom.: 1 Cov.: 32 AF XY: 0.000134 AC XY: 10AN XY: 74392
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 20, 2018 | The p.P38L variant (also known as c.113C>T), located in coding exon 1 of the PRICKLE1 gene, results from a C to T substitution at nucleotide position 113. The proline at codon 38 is replaced by leucine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Mar 12, 2018 | The P38L variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The P38L variant is observed in 77/18,870 (0.4%) alleles from individuals of East Asian background (Lek et al., 2016). The P38L variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. In-silico analyses, including protein predictors and evolutionary conservation, support a deleterious effect. Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. - |
Epilepsy, progressive myoclonic, 1B Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Invitae | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at